Fri, Jul 25, 2014, 9:20 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Neurocrine Biosciences Inc. Message Board

  • beachbarbob beachbarbob Jan 13, 2012 10:21 AM Flag

    Anthing of interest said

    at the JP Morgan conference?

    TIA

    beach

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Lazay boy, here are hight lights:
      1). UCN2 phase II trial was completed last week, topline data will be reported later Feb or earlier March.
      2). 32 patient VAMT2 phase II trial completed its enrollment, topline data will be reported before the end of March
      3). VMAT2 program itself is a pipeline, preclinical data has shown it is was as effective as haloperidol is to treat Schizophrenia, Gorman was certainly more confident in his VMAT2 program future now than before because he must knew the ongoing trial site patient positive experiences; otherwise, he should only pump the VMAT2 program after the current trial is completed
      4). Elagolix phase III trial will happen quickly - that is Gorman's original statement, no particular date was mentioned by him.

      My prediction is THE TRIAN is going to leave the station before the end of March

 
NBIX
13.53-0.14(-1.02%)Jul 25 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.